Novartis — Sandoz
Tracked across 3 events · 21 articles · First seen Oct 29, 2025 · Last active Jun 30, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Novartis — Sandoz validated the J.TRAIN model through a December 2025 transaction, which included a manufacturing facility and a license to Evotec's proprietary manufacturing technology, demonstrating the feasibility and scalability of the new offering.
Jun 30, 2026 · 7 articles
Business
Impact: Novartis — Sandoz expanded its development and commercialization partnership with Samsung Biologics — Samsung Biologics for biosimilar candidates.
Apr 23, 2026 · 6 articles
Regulatory
Impact: Novartis — Sandoz is mentioned as a company that has previously recalled drugs due to nitrosamine contamination, providing context to the current event.
Oct 29, 2025 · 8 articles
60
Evotec completed transaction Novartis — SandozEvotec launches J.TRAIN...
ERGEN INTELLIGENCE
Track Novartis — Sandoz live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard